Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 1999 Dec;75(6):412–416. doi: 10.1136/sti.75.6.412

High prevalence of genital Chlamydia trachomatis infection in women presenting in different clinical settings in Jamaica: implications for control strategies

G Dowe, M Smikle, S D King, H Wynter, J Frederick, T Hylton-Kong
PMCID: PMC1758250  PMID: 10754948

Abstract

OBJECTIVE: To determine the prevalence of genital Chlamydia trachomatis infection and risk factors in women attending family planning, gynaecology, and sexually transmitted disease (STD) clinics in Jamaica. METHODS: Endocervical specimens from 645 women including 238 family planning, 170 gynaecology, and 237 STD clinic attendees were examined for C trachomatis using a direct fluorescence assay (DFA) and culture. Investigations were carried out for the presence of other STD pathogens and demographic, behavioural, historical, and clinical data recorded for each participant. RESULTS: The prevalence of C trachomatis infection was 35%, 47%, and 55% in family planning, gynaecology, and STD clinic clients, respectively. The performance of the DFA was comparable to that of culture in screening for C trachomatis. Logistic regression analysis revealed that the independent risk factors for C trachomatis infection were non-barrier contraceptive methods in family planning clients (OR = 2.1; 95% confidence interval (CI) = 1.2-3.9; p = 0.0110), cervical ectopy in gynaecology clients (OR = 3.9; 95% CI = 1.4-10.6; p = 0.0076) and concomitant Trichomonas vaginalis infection in STD clients (OR = 3.5; 95% CI = 1.8-6.8; p = 0.003). Age, number of sex partners, and reason for visit were not identified as risk factors for C trachomatis infection. CONCLUSIONS: Consistently high prevalence of C trachomatis infection occurs in Jamaican women. Universal screening or presumptive treatment should be evaluated as prevention and control measures for C trachomatis infection in this population where all women appear to be at risk. 




Full Text

The Full Text of this article is available as a PDF (83.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addiss D. G., Vaughn M. L., Golubjatnikov R., Pfister J., Kurtycz D. F., Davis J. P. Chlamydia trachomatis infection in women attending urban midwestern family planning and community health clinics: risk factors, selective screening, and evaluation of non-culture techniques. Sex Transm Dis. 1990 Jul-Sep;17(3):138–146. doi: 10.1097/00007435-199007000-00006. [DOI] [PubMed] [Google Scholar]
  2. Behets F. M., Williams Y., Brathwaite A., Hylton-Kong T., Hoffman I. F., Dallabetta G., Ward E., Cohen M. S., Figueroa J. P. Management of vaginal discharge in women treated at a Jamaican sexually transmitted disease clinic: use of diagnostic algorithms versus laboratory testing. Clin Infect Dis. 1995 Dec;21(6):1450–1455. doi: 10.1093/clinids/21.6.1450. [DOI] [PubMed] [Google Scholar]
  3. Dowe G., King S. D., Brathwaite A. R., Wynter Z., Chout R. Genital Chlamydia trachomatis (serotypes D-K) infection in Jamaican commercial street sex workers. Genitourin Med. 1997 Oct;73(5):362–364. doi: 10.1136/sti.73.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dowe G., King S. D., Smikle M. F., Wynter H. H., Chout R., Klaskala W. Prevalence of viral and bacterial sexually transmitted pathogens in Jamaican pregnant women. West Indian Med J. 1998 Mar;47(1):23–25. [PubMed] [Google Scholar]
  5. Howell M. R., Quinn T. C., Gaydos C. A. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med. 1998 Feb 15;128(4):277–284. doi: 10.7326/0003-4819-128-4-199802150-00005. [DOI] [PubMed] [Google Scholar]
  6. Humphreys J. T., Henneberry J. F., Rickard R. S., Beebe J. L. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics. Sex Transm Dis. 1992 Jan-Feb;19(1):47–53. doi: 10.1097/00007435-199201000-00010. [DOI] [PubMed] [Google Scholar]
  7. Kent G. P., Harrison H. R., Berman S. M., Keenlyside R. A. Screening for Chlamydia trachomatis infection in a sexually transmitted disease clinic: comparison of diagnostic tests with clinical and historical risk factors. Sex Transm Dis. 1988 Jan-Mar;15(1):51–57. doi: 10.1097/00007435-198801000-00012. [DOI] [PubMed] [Google Scholar]
  8. King S. D., Dowe G., Wynter H. H., Brathwaite A. R. Chlamydial infections in selected populations in Jamaica. West Indian Med J. 1992 Dec;41(4):136–138. [PubMed] [Google Scholar]
  9. Magder L. S., Harrison H. R., Ehret J. M., Anderson T. S., Judson F. N. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol. 1988 Aug;128(2):298–308. doi: 10.1093/oxfordjournals.aje.a114970. [DOI] [PubMed] [Google Scholar]
  10. Marrazzo J. M., Fine D., Celum C. L., DeLisle S., Handsfield H. H. Selective screening for chlamydial infection in women: a comparison of three sets of criteria. Fam Plann Perspect. 1997 Jul-Aug;29(4):158–162. [PubMed] [Google Scholar]
  11. Mosure D. J., Berman S., Fine D., DeLisle S., Cates W., Jr, Boring J. R., 3rd Genital Chlamydia infections in sexually active female adolescents: do we really need to screen everyone? J Adolesc Health. 1997 Jan;20(1):6–13. doi: 10.1016/S1054-139X(96)00157-7. [DOI] [PubMed] [Google Scholar]
  12. Pabst K. M., Reichart C. A., Knud-Hansen C. R., Wasserheit J. N., Quinn T. C., Shah K., Dallabetta G., Hook E. W., 3rd Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit. Sex Transm Dis. 1992 Mar-Apr;19(2):88–91. [PubMed] [Google Scholar]
  13. Sciarra J. J. Sexually transmitted diseases: global importance. Int J Gynaecol Obstet. 1997 Jul;58(1):107–119. doi: 10.1016/s0020-7292(97)02867-1. [DOI] [PubMed] [Google Scholar]
  14. Stergachis A., Scholes D., Heidrich F. E., Sherer D. M., Holmes K. K., Stamm W. E. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol. 1993 Aug 1;138(3):143–153. doi: 10.1093/oxfordjournals.aje.a116840. [DOI] [PubMed] [Google Scholar]
  15. Theunissen J. J., Kariwiga G., Ossewaarde J. M., van Rijsoort-Vos J. H., Stolz E., van der Meijden W. I. Prevalence of Chlamydia trachomatis in women attending a family planning clinic in Papua New Guinea. Genitourin Med. 1995 Oct;71(5):295–298. doi: 10.1136/sti.71.5.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wasti S., Ashfaq M. K., Ishaq R., Hamid R. Prevalence of chlamydial infection in females attending antenatal and family planning clinics in Karachi Pakistan. Aust N Z J Obstet Gynaecol. 1997 Nov;37(4):462–465. doi: 10.1111/j.1479-828x.1997.tb02461.x. [DOI] [PubMed] [Google Scholar]
  17. Weinstock H. S., Bolan G. A., Kohn R., Balladares C., Back A., Oliva G. Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations? Am J Epidemiol. 1992 Jan 1;135(1):41–47. doi: 10.1093/oxfordjournals.aje.a116200. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES